Scimplify Raises $40 Million Series B Funding to Expand Specialty Chemicals Access

Scimplify, an Indian startup focused on connecting pharmaceutical and agriculture companies with specialty chemical producers, has successfully raised $40 million in a Series B funding round co-led by Accel and Bertelsmann Investments, bringing its total funding to $54 million. The investment aims to enhance Scimplify's global presence, particularly in the U.S., and expand its reach into new markets while leveraging its platform, ATOMS, which showcases specialty chemicals from a network of over 200 manufacturers across multiple countries. The company addresses the challenges posed by geopolitical tensions affecting traditional supply chains, primarily those reliant on Chinese suppliers. With a valuation of approximately $150 million post-investment, Scimplify has served around 600 clients across 16 countries, providing tailored solutions and semi-annual audits to ensure quality from its manufacturing partners. The startup's unique model allows customers to easily access and switch between various chemical solutions without significant capital investment. Co-founder Sachin Santhosh emphasized the importance of adapting to the rapidly changing global supply chains and the need for reliable manufacturing partners.